Medication Management at the End of Life: implications for clinical practice from the EU Horizon 2020 iLIVE Project

Consensus-based recommendations for deprescribing medication at the end of life

Dr Eric Geijteman MD PhD, medical oncologist and clinical pharmacologist, Erasmus University Medical Centre, Rotterdam, Netherlands

Patients in the last phase of life often take many medications. On the one hand, this is necessary because the symptom burden increases as death approaches. On the other hand, unnecessary medications are often continued until just before death. In this talk, Dr Geijtemann will discuss optimizing medication use in the last phase of life.

A Clinical Decision Support System for medication management at the end of life

Iris Pot MSc, PhD candidate, Erasmus University Medical Centre, Rotterdam, Netherlands

Patients in the last phase of life often use several potentially inappropriate medications, which may negatively affect their quality of life. Physicians are often reluctant to deprescribe these medications because of insufficient evidence on the effects and limited experience. A clinical decision support system (CDSS-OPTIMED)…